Literature DB >> 11812672

Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. Assessment of Cardioversion Using Transoesophageal Echocardiography. AzimiLide post-Infarct surVival Evaluation. Randomised Evaluation of Mechanical Assistance for Treatment of Chronic Heart failure.

Amala A Louis1, I Renata Manousos, Alison P Coletta, Andrew L Clark, John G F Cleland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11812672     DOI： 10.1016/s1388-9842(01)00240-9

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  13 in total

1.  Depression, stress, and the heart.

Authors:  P C Strike; A Steptoe
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  Psychological stress and cardiovascular disease. Rose questionnaire is not what it seems.

Authors:  Matthew Hotopf
Journal:  BMJ       Date:  2002-08-10

Review 3.  Psychosocial factors and public health: a suitable case for treatment?

Authors:  J Macleod; G Davey Smith
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

Review 4.  Use of nicorandil in cardiovascular disease and its optimization.

Authors:  Shigeo Horinaka
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

Review 5.  Psychological interventions for coronary heart disease.

Authors:  Suzanne H Richards; Lindsey Anderson; Caroline E Jenkinson; Ben Whalley; Karen Rees; Philippa Davies; Paul Bennett; Zulian Liu; Robert West; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-04-28

6.  Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.

Authors:  Gernot Schram; Liming Zhang; Katayoun Derakhchan; Joachim R Ehrlich; Luiz Belardinelli; Stanley Nattel
Journal:  Br J Pharmacol       Date:  2004-07-26       Impact factor: 8.739

7.  Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Authors:  Charles Antzelevitch; Luiz Belardinelli; Andrew C Zygmunt; Alexander Burashnikov; José M Di Diego; Jeffrey M Fish; Jonathan M Cordeiro; George Thomas
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

8.  Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.

Authors:  Sandra Fredj; Kevin J Sampson; Huajun Liu; Robert S Kass
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 9.  [Depressive disorders with somatic illnesses].

Authors:  V Arolt; M Rothermundt
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

10.  Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress.

Authors:  Wanqing Sun; Nanhu Quan; Lin Wang; Hui Yang; Dongyang Chu; Quan Liu; Xuezhong Zhao; Jiyan Leng; Ji Li
Journal:  Toxicol Sci       Date:  2016-02-15       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.